15.75
price down icon7.13%   -1.21
after-market Handel nachbörslich: 15.51 -0.24 -1.52%
loading

Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
16.22%
0.0822
0.0981 0.1123 0.1282 0.0905
Operating Expenses
9.86%
1.7234
1.912 2.066 2.3282 2.525
Benefits Costs and Expenses
-
- - - 2.525
Costs And Expenses
10.17%
1.8056
2.0101 2.1783 2.4564 2.525
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
9.86%
-1.7234
-1.912 -2.066 -2.3282 -2.525
Net Interest Income/Expense
16.22%
0.0822
0.0981 0.1123 0.1282 0.0905
Interest Income/Expense After Provision For Losses
16.22%
0.0822
0.0981 0.1123 0.1282 0.0905
Income/Loss From Continuing Operations Before Tax
16.22%
0.0822
0.0981 0.1123 -2.20 -2.4346
Income/Loss From Continuing Operations After Tax
9.52%
-1.6412
-1.8139 -1.9537 -2.20 -2.4346
Net Income/Loss
9.52%
-1.6412
-1.8139 -1.9537 -2.20 -2.4346
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,771%
15.98
0.2722 14.12 13.42 -0.1563
Basic Earnings Per Share
16.67%
-0.10
-0.12 -0.14 -0.16 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):